About
Antiviral Therapies
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
325
By Phase
EARLY_PHASE1: 1PHASE2: 3PHASE1: 1
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05737433Lead Sponsor
Single Dose ADME Study of [14C]-Rencofilstat in Healthy Male Subjects
EARLY_PHASE1Completed
6 participants
Started: Mar 1, 2023 · Completed: Aug 4, 2023
NCT05402371Lead Sponsor
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
PHASE2Active, not recruiting
120 participants
Started: Oct 15, 2022 · Completed: Sep 30, 2025
NCT05461105Lead Sponsor
A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3
PHASE2Completed
60 participants
Started: Mar 15, 2022 · Completed: Jul 7, 2023
NCT04480710Lead Sponsor
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects
PHASE2Completed
47 participants
Started: Jun 23, 2020 · Completed: Oct 30, 2021
NCT03596697Lead Sponsor
A Study in Healthy Volunteers
PHASE1Completed
92 participants
Started: Jul 9, 2019 · Completed: Jun 4, 2021
Locations (1)
Headquarters
Edison, NJ, United States
Map
Loading map...